These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29335847)

  • 21. Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients.
    Lee DW; Han SW; Cha Y; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Park JW; Ryoo SB; Jeong SY; Kang GH; Park KJ; Kim TY
    BMC Cancer; 2015 Oct; 15():690. PubMed ID: 26467912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China.
    Li X; An B; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Surg; 2018 Aug; 56():188-194. PubMed ID: 29936197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging?
    Cianchi F; Messerini L; Palomba A; Boddi V; Perigli G; Pucciani F; Bechi P; Cortesini C
    Dis Colon Rectum; 1997 Oct; 40(10):1170-5; discussion 1175-6. PubMed ID: 9336111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
    Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
    Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy.
    Ottaiano A; Nappi A; Tafuto S; Nasti G; De Divitiis C; Romano C; Cassata A; Casaretti R; Silvestro L; Avallone A; Capuozzo M; Capozzi M; Maiolino P; Quagliariello V; Scala S; Iaffaioli VR
    Oncology; 2016; 90(1):36-42. PubMed ID: 26731722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Weight Change after Colorectal Cancer Diagnosis and Outcomes in the Kaiser Permanente Northern California Population.
    Meyerhardt JA; Kroenke CH; Prado CM; Kwan ML; Castillo A; Weltzien E; Cespedes Feliciano EM; Xiao J; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):30-37. PubMed ID: 27986654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.
    Kim CH; Huh JW; Kim HJ; Lim SW; Song SY; Kim HR; Na KJ; Kim YJ
    Dis Colon Rectum; 2012 Apr; 55(4):459-64. PubMed ID: 22426271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disentangling the prognostic heterogeneity of stage III colorectal cancer through histologic stromal categorization.
    Ueno H; Sekine S; Oshiro T; Kanemitsu Y; Hamaguchi T; Shida D; Takashima A; Ishiguro M; Ito E; Hashiguchi Y; Kondo F; Shimazaki H; Mochizuki S; Kajiwara Y; Shinto E; Yamamoto J; Shimada Y
    Surgery; 2018 Apr; 163(4):777-783. PubMed ID: 29162344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Anastomotic Leak After Elective Colorectal Cancer Resection on Survival and Local Recurrence: A Propensity Score Analysis.
    Zimmermann MS; Wellner U; Laubert T; Ellebrecht DB; Bruch HP; Keck T; Schlöricke E; Benecke CR
    Dis Colon Rectum; 2019 Mar; 62(3):286-293. PubMed ID: 30540662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis.
    Asghari-Jafarabadi M; Hajizadeh E; Kazemnejad A; Fatemi SR
    Asian Pac J Cancer Prev; 2009; 10(5):815-21. PubMed ID: 20104971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations.
    Kocarnik JM; Chan AT; Slattery ML; Potter JD; Meyerhardt J; Phipps A; Nan H; Harrison T; Rohan TE; Qi L; Hou L; Caan B; Kroenke CH; Strickler H; Hayes RB; Schoen RE; Chong DQ; White E; Berndt SI; Peters U; Newcomb PA
    Int J Cancer; 2016 Sep; 139(5):1065-72. PubMed ID: 27121247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of lymph node ratio in stage III colorectal cancer.
    Wong KP; Poon JT; Fan JK; Law WL
    Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association of peripheral nerve invasion with clinicopathological factors and prognosis of colorectal cancer].
    Han D; Wei Y; Wang X; Wang G; Chen Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):62-66. PubMed ID: 28105622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy.
    Simkens LH; Koopman M; Mol L; Veldhuis GJ; Ten Bokkel Huinink D; Muller EW; Derleyn VA; Teerenstra S; Punt CJ
    Eur J Cancer; 2011 Nov; 47(17):2560-7. PubMed ID: 21803570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of distant metastasis sites and surgery in stage IV colorectal cancer: a population-based study.
    Luo D; Liu Q; Yu W; Ma Y; Zhu J; Lian P; Cai S; Li Q; Li X
    Int J Colorectal Dis; 2018 Sep; 33(9):1241-1249. PubMed ID: 29931408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer.
    Yamamoto N; Fujii S; Sato T; Oshima T; Rino Y; Kunisaki C; Masuda M; Imada T
    Asia Pac J Clin Oncol; 2012 Dec; 8(4):337-45. PubMed ID: 22897609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.